Ensemble Therapeutics

Ensemble Therapeutics Corp.
private
Industry Health care
Biotechnology
Founded 2004 (2004)
Founder David R. Liu
Headquarters Cambridge, Massachusetts, United States
Key people
 Michael D. Taylor
Nick K. Terrett
Products Ensemblins™ (under development)
Website ensembletherapeutics.com

Ensemble Therapeutics Corporation is a privately held pharmaceutical and biotechnology company in Cambridge, Massachusetts. Founded in 2004 by Harvard chemist David R. Liu, the company develops and is attempting to bring to market synthetic macrocycle drugs, that is, compounds with a characteristic macrocyclic ring structure, under the trademark Ensemblins. If successful, Ensemblins would be a new class of drugs between small molecules and biologics. An orally active antagonist to Interleukin 17 has been demonstrated in animal models.[1]

Management

John Ripple became chief executive officer in 2013. Nick K. Terrett has been the chief scientific officer since 2006. Founder David R. Liu chairs the scientific advisory board.[2]

Ownership

Ensemble is principally owned by Flagship Ventures, a venture capital firm whose founder, Noubar Afeyan, chairs its board.[3] Other investors include ARCH Venture Partners, CMEA, Harris & Harris, Kisco Ltd., and Boston University. As of 2012, Ensemble has raised $38.5 million of equity financing.[1]

Partnerships

Ensemble has entered into partnerships that allow its macrocycle libraries to be accessed for the purpose of affinity screening drug discovery against targets that are otherwise difficult to address. Partner firms include Novartis, Alexion, Boehringer Ingelheim, Genentech, Bristol-Myers Squibb, and Pfizer.[4][5]

References

  1. 1 2 "Ensemble Therapeutics Fact Sheet" (November 28, 2012)
  2. ↑ BloombergBusinessweek, "Company Overview of Ensemble Therapeutics Corporation"
  3. ↑ Flagship Ventures, "Ensemble Therapeutics Corporation"
  4. ↑ BusinessWire, "Ensemble Therapeutics Presents Data Demonstrating Unique Properties of Synthetic Macrocycles" (February 13, 2013)
  5. ↑ BusinessWire, "Ensemble Therapeutics Extends Macrocycle Drug Discovery Alliance with Bristol-Myers Squibb"(January 5, 2012)


This article is issued from Wikipedia - version of the 11/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.